Del buys X-Ray Technologies
Del Global Technologies has acquired X-Ray Technologies, a developer of low-cost x-ray systems for the private-office, veterinary, and chiropractic markets. Del has integrated its purchase into its Universal product line to form a new division,
Del Global Technologies has acquired X-Ray Technologies, a developer of low-cost x-ray systems for the private-office, veterinary, and chiropractic markets. Del has integrated its purchase into its Universal product line to form a new division, Universal/X-Tek, that will sell products under the Universal and X-Tek trade names.
X-Ray Technologies was founded in 1994 and began selling systems in 1996. The company's products include lightweight full-body x-ray systems that sell in the range of $10,000 to $15,000, making them cost-effective for smaller medical facilities, according to Leonard Trugman, Del chairman, CEO, and president. X-Ray Technologies had revenues of over $1 million last year, Trugman said.
Del believes it can boost sales of the X-Ray Technologies product line by plugging the systems into the Del distribution network. Del is especially enthusiastic about the potential of the systems in international markets, such as in developing countries.
As part of the acquisition, X-Ray Technologies president and founder Randy Duffy will be general manager of the Universal/X-Tek division, reporting to John Mankowich, vice president and general manager of Del's Gendex-Del Medical Imaging subsidiary.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
